Frequently asked questions about adverse drug reactions of methylphenidate
Research output: Contribution to journal › Journal article › Research › peer-review
This article addresses frequently asked questions about the adverse drug reactions associated with methylphenidate treatment. Methylphenidate is a central nervous system stimulant used primarily for the treatment of attention-deficit/hyperactivity disorder. It utilizes insights from the combined knowledge of pharmacists and physicians who advise healthcare professionals in the Capital Region of Denmark on patient-specific medication queries. The article provides an overview of the clinical challenges and safety considerations associated with methylphenidate use, integrating empirical data and clinical expertise to facilitate informed decision-making by practitioners.
Original language | English |
---|---|
Journal | Adverse Drug Reaction Bulletin |
Volume | 345 |
Issue number | 1 |
Pages (from-to) | 1339-1342 |
Number of pages | 4 |
ISSN | 0044-6394 |
DOIs | |
Publication status | Published - 2024 |
Bibliographical note
Publisher Copyright:
© 2024 Lippincott Williams and Wilkins. All rights reserved.
ID: 394434940